dexcoman American company specializing in the continuous glucose monitoring (MCG), presents in Spain from Dexcom G6 system for people with diabetesthat eliminates routine punctures for people with diabetes and is almost a third smaller than the previous generation.
Dexcom G6 includes new characteristics that allow users take control of your diabetes more comfortably:
- puncture removal for calibration and decision making in the treatment of diabetes
- Customizable alarm and alerts to warn users and their designated followers of dangerous glucose levels, even when asleep, a feature particularly useful for children and patients with impaired consciousness due to hypoglycemia
- A sensor whose service life has been extended up to 10 days (43% longer than previous generation Dexcom G5)
- A new and smaller transmitter with a 28% lower profile than the previous generation
- A self applicator designed to make sensor insertion very simple and as painless as possible with the push of a button
- Continuous glucose readings sent automatically every 5 minutes via bluetooth technology to any compatible smart device, or to a Dexcom receiver
- new membrane on the sensor that allows the use of Paracetamol without any effect on glucose readings
Furthermore, with the Dexcom G6 app users can share the information about glucose levels with up to five people. This system of continuous glucose monitoring allows integrated monitoring of levels so that people in the user’s environment can control them remotely for greater peace of mind.
“Dexcom G6 represents the future of diabetes treatment. Not only does it eliminate the need for punctures, but it also maintains the performance, connectivity and precision What the diabetes community expects from Dexcom CGM»stands out John ListerCEO ofand for EMEA.
For his part, Francisco Crespodirector of (which distributes to Dexcom in Spain), states that “With the new Dexcom G6, capillary glucose measurement will become a thing of the past. The G6 is one of the most effective tools today to make it easier for people with type 1 diabetes to accurately monitor their blood glucose levels and will eliminate the burden of routine testing and calibration, which can be time consuming and painful. This is a huge step forward for the diabetes community and will undoubtedly lead to a better life quality for people living with this condition”.